Satellos Bioscience Inc. — Form D

Satellos Bioscience Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-27. The offering totals $2.1M, of which $99K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Michael RudnickiPromoterToronto, A6
Franklin D BergerDirectorToronto, A6
Frank GleesonDirectorToronto, A6
Frank GleesonExecutive OfficerToronto, A6
Frank GleesonPromoterToronto, A6
Michael Robert CrossExecutive OfficerToronto, A6
William McVicarDirectorToronto, A6
Brian BloomDirectorToronto, A6
Elizabeth WilliamsExecutive OfficerCroton on Hudson, NY
Stephanie D BrownDirectorToronto, A6
Michael RudnickiExecutive OfficerToronto, A6
Bill JaroszDirectorToronto, A6
Adam MostafaDirectorToronto, A6
Philip D LambertExecutive OfficerToronto, A6
Courtney D WellsExecutive OfficerToronto, A6
Geoff MacKayDirectorToronto, A6
Rima Al-awarDirectorToronto, A6
Michael LiggettDirectorVancouver, A1
Michael LiggettExecutive OfficerVancouver, A1
J. Robert HallExecutive OfficerToronto, A6
Warren WhiteheadExecutive OfficerToronto, A6
SUSAN KOPPYDirectorVANCOUVER, A1
ANDREW RAEDirectorVANCOUVER, A1
ANDREW RAEExecutive OfficerVANCOUVER, A1
WILLIAM JAROSZDirectorVANCOUVER, A1

Other filings by this issuer (9)

FiledFormOfferingSold
2025-01-03D$25.0M$25.0M
2023-05-25D$33.3M$33.3M
2019-09-10D$2.5M$188K
2019-03-08D$972K$152K
2014-02-05D$7.9M$2.0M
2013-11-21D/A$126K$126K
2011-11-15D$50K$50K
2009-12-01D/A$3.3M$3.3M
2009-11-06D$2.7M$2.7M

More